• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDX-2, a new marker for adenocarcinoma of gastrointestinal origin.

作者信息

Li Melissa K, Folpe Andrew L

机构信息

Department of Pathology, University of Florida, Gainesville, Florida, USA.

出版信息

Adv Anat Pathol. 2004 Mar;11(2):101-5. doi: 10.1097/00125480-200403000-00004.

DOI:10.1097/00125480-200403000-00004
PMID:15090846
Abstract

CDX2-88 is a recently developed monoclonal antibody to the intestinal epithelia-specific nuclear transcription factor CDX2. CDX2 immunohistochemistry has recently been shown to be useful in establishing gastrointestinal origin in metastatic tumors and will likely become a useful addition to the standard panel of immunostains for carcinomas of unknown primary sites. This article reviews the previous studies of this new antibody.

摘要

相似文献

1
CDX-2, a new marker for adenocarcinoma of gastrointestinal origin.
Adv Anat Pathol. 2004 Mar;11(2):101-5. doi: 10.1097/00125480-200403000-00004.
2
CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.CDX2,一种高度敏感且特异的肠道原发性腺癌标志物:476例原发性和转移性癌的免疫组化研究
Am J Surg Pathol. 2003 Mar;27(3):303-10. doi: 10.1097/00000478-200303000-00003.
3
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.CDX-2 同源盒基因表达是结直肠癌肺转移的可靠标志物。
Am J Surg Pathol. 2003 Feb;27(2):141-9. doi: 10.1097/00000478-200302000-00001.
4
Diagnostic utility of CDX-2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks.在利用细胞块的细针穿刺细胞学检查中,CDX-2表达在鉴别转移性胃肠道腺癌与其他转移性腺癌方面的诊断效用。
Cancer. 2004 Jun 25;102(3):168-73. doi: 10.1002/cncr.20342.
5
CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.CDX2免疫染色作为一种胃肠道标志物:在肺癌中的表达是一个潜在陷阱。
Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):55-60. doi: 10.1097/00129039-200503000-00009.
6
Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.CDX-2和TTF-1表达在鉴别不明原发灶转移性神经内分泌肿瘤中的诊断价值
Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):407-14. doi: 10.1097/01.pai.0000210416.53493.0f.
7
CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.CDX2 可能是一个有用的标志物,有助于鉴别卵巢原发性类癌与胃肠道转移至卵巢的类癌。
Hum Pathol. 2013 Nov;44(11):2536-41. doi: 10.1016/j.humpath.2013.06.014. Epub 2013 Sep 9.
8
Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.甲状腺转录因子-1和CDX-2在确定浆液性积液中转移性腺癌原发部位的作用
Acta Cytol. 2010 May-Jun;54(3):277-82. doi: 10.1159/000325035.
9
Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.在鼻窦肿瘤中,CDX-2免疫表达并不局限于肠型腺癌。
Head Neck Pathol. 2014 Mar;8(1):59-65. doi: 10.1007/s12105-013-0475-7. Epub 2013 Jul 12.
10
CDX-2 immunostaining in primary and secondary ovarian carcinomas.原发性和继发性卵巢癌中的CDX-2免疫染色
J Clin Pathol. 2004 Jun;57(6):641-3. doi: 10.1136/jcp.2003.013615.

引用本文的文献

1
Cervical and vaginal metastases from ascending colon cancer: a case report and literature review.升结肠癌的宫颈和阴道转移:一例报告及文献复习
BMC Womens Health. 2025 Jul 25;25(1):369. doi: 10.1186/s12905-025-03913-x.
2
Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management.II期结直肠癌中的蛋白质预后生物标志物:对术后管理的意义。
BJC Rep. 2024 Feb 13;2(1):13. doi: 10.1038/s44276-024-00043-z.
3
The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers.
在接受辅助性FOLFOX治疗的III期结直肠癌患者中,CDX2表达状态与肿瘤浸润淋巴细胞密度的联合作为一种预后因素。
J Pathol Transl Med. 2025 Jan;59(1):50-59. doi: 10.4132/jptm.2024.09.26. Epub 2024 Oct 24.
4
Uterine cervix metastasis from primary colon adenocarcinoma: a case report and review of the literature.原发结肠癌转移至子宫颈:病例报告及文献复习。
J Med Case Rep. 2021 Oct 2;15(1):486. doi: 10.1186/s13256-021-03055-2.
5
Two Cases of Sinonasal Non-Intestinal-Type Adenocarcinoma with Squamoid Morules Expressing Nuclear -Catenin and CDX2: A Curious Morphologic Finding Supported by Molecular Analysis.两例伴有表达核β-连环蛋白和CDX2的鳞状小体的鼻窦非肠型腺癌:一项由分子分析支持的奇特形态学发现
Case Rep Pathol. 2018 Sep 13;2018:8741017. doi: 10.1155/2018/8741017. eCollection 2018.
6
Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.胃肠道、胰腺、肺和胸腺神经内分泌肿瘤的免疫组织化学生物标志物。
Endocr Pathol. 2018 Jun;29(2):150-168. doi: 10.1007/s12022-018-9522-y.
7
CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.睾丸原发性和转移性生殖细胞肿瘤中的CDX2免疫染色。
J Int Med Res. 2016 Dec;44(6):1323-1330. doi: 10.1177/0300060516665472. Epub 2016 Nov 11.
8
Synchronous ovarian metastasis from colorectal cancer: A report of two cases.结直肠癌的同步性卵巢转移:两例报告
Oncol Lett. 2016 Jul;12(1):257-261. doi: 10.3892/ol.2016.4553. Epub 2016 May 11.
9
Uterine cervix metastasis from a sigmoid adenocarcinoma: a rare presentation of an uncommon tumor.乙状结肠腺癌子宫颈转移:一种罕见肿瘤的罕见表现。
Gynecol Oncol Res Pract. 2014 Dec 1;1:6. doi: 10.1186/2053-6844-1-6. eCollection 2014.
10
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.CDX2作为II期和III期结肠癌的预后生物标志物
N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.